-
公开(公告)号：US20150336958A1
公开(公告)日：2015-11-26
申请号：US14820884
申请日：2015-08-07
Applicant: PFIZER INC.
IPC: C07D471/10
CPC classification number: C07D471/10 , C07D519/00
Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 areas described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
Abstract translation: 本发明提供式（I）化合物或其药学上可接受的盐; 其中G为本文所述的R1，R2和R3区; 其药物组合物; 以及其用于治疗通过抑制动物体内的乙酰辅酶A羧化酶调节的疾病，病症或病症的用途。
-
公开(公告)号：US20150112068A1
公开(公告)日：2015-04-23
申请号：US14593370
申请日：2015-01-09
Applicant: PFIZER INC.
IPC: C07D471/10
CPC classification number: C07D471/10 , C07D519/00
Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 areas described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
-
公开(公告)号：US20140323730A1
公开(公告)日：2014-10-30
申请号：US14325420
申请日：2014-07-08
Applicant: Pfizer Inc.
IPC: C07D471/10
CPC classification number: C07D471/10 , C07D519/00
Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
Abstract translation: 本发明提供式（I）化合物或其药学上可接受的盐; 其中G为R 1，R 2和R 3如本文所述; 其药物组合物; 以及其用于治疗通过抑制动物体内的乙酰辅酶A羧化酶调节的疾病，病症或病症的用途。
-
-
Search Results
3
records
(took 0.018 seconds)
